Evidence map›Paper›PMID 30659077›Full record

ArticleDiabetes care2019

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.

Suna Onengut-Gumuscu, Wei-Min Chen, Catherine C Robertson, Jessica K Bonnie, Emily Farber, Zhennan Zhu, Jorge R Oksenberg, Steven R Brant, S Louis Bridges, Jeffrey C Edberg and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Phenotypic and Genetic Diversity in Diabetes Across Populations.The Journal of clinical endocrinology and metabolism · 2025
    Review
  20. Type 1 Diabetes Genetics Consortium.The Journal of clinical endocrinology and metabolism · 2025
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 1 country.

Suna Onengut-GumuscuCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.ORCID 0000-0002-6563-8334
Wei-Min ChenCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.
Catherine C RobertsonCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.
Jessica K BonnieCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.
Emily FarberCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.
Zhennan ZhuCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.
Jorge R OksenbergDepartment of Neurology, School of Medicine, University of California, San Francisco, San Francisco, CA.
Steven R BrantMeyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School of Medicine, and Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
S Louis BridgesDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL.
Jeffrey C EdbergDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL.
Robert P KimberlyDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL.
Peter K GregersenRobert S. Boas Center for Genomics & Human Genetics, The Feinstein Institute for Medical Research, Manhasset, NY.
Marian J RewersBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO.
Andrea K SteckBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO.ORCID 0000-0002-5931-9484
Mary H BlackAmbry Genetics, Aliso Viejo, CA.
Dana DabeleaColorado School of Public Health, University of Colorado Denver, Aurora, CO.ORCID 0000-0001-9514-8929
Catherine PihokerDepartment of Pediatrics, University of Washington, Seattle, WA.ORCID 0000-0001-9074-7770
Mark A AtkinsonDiabetes Institute and Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
Lynne E WagenknechtDepartment of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
Jasmin DiversDepartment of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Ronny A BellDepartment of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
SEARCH for Diabetes in Youth
Type 1 Diabetes Genetics Consortium
Henry A ErlichCenter for Genetics, Children's Hospital Oakland Research Institute, Oakland, CA.
Patrick ConcannonCenter for Public Health Genomics, University of Virginia, Charlottesville, VA.ORCID 0000-0002-5801-1859
Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, VA ssr4n@virginia.edu.ORCID 0000-0003-3872-7793
University of Virginia · USUniversity of Alabama at Birmingham · USWake Forest University · USUniversity of Colorado Denver · USAmbry Genetics (United States) · USColorado School of Public Health · USFeinstein Institute for Medical Research · USJohns Hopkins University · USUniversity of California, San Francisco · USUniversity of Florida · USUniversity of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
IBD Gene Mapping by Clinical and Population SubsetsU01DK062431 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Steven R Brant · 2002 to 2026
$10.7M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
HSRD VA HIR 10-001NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR002319NCCDPHP CDC HHS U01 DP000244NCCDPHP CDC HHS U01 DP000246NCCDPHP CDC HHS U01 DP000247NCCDPHP CDC HHS U01 DP000248NCCDPHP CDC HHS U01 DP000250NCCDPHP CDC HHS U01 DP000254NCCDPHP CDC HHS U18 DP002708NCCDPHP CDC HHS U18 DP002709NCCDPHP CDC HHS U18 DP002710NCCDPHP CDC HHS U18 DP002714NHGRI NIH HHS R01 HG008965NIAID NIH HHS P01 AI042288NIAMS NIH HHS P01 AR049084NIDDK NIH HHS DP3 DK085678NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK057516NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK046635NIDDK NIH HHS R01 DK096926NIDDK NIH HHS R01 DK106718NIDDK NIH HHS U01 DK062418NIDDK NIH HHS U01 DK062431NLM NIH HHS T32 LM012416
6 · The paper itself

Abstract

objectiveGenetic risk scores (GRS) have been developed that differentiate individuals with type 1 diabetes from those with other forms of diabetes and are starting to be used for population screening; however, most studies were conducted in European-ancestry populations. This study identifies novel genetic variants associated with type 1 diabetes risk in African-ancestry participants and develops an African-specific GRS. RESEARCH DESIGN AND

methodsWe generated single nucleotide polymorphism (SNP) data with the ImmunoChip on 1,021 African-ancestry participants with type 1 diabetes and 2,928 control participants. HLA class I and class II alleles were imputed using SNP2HLA. Logistic regression models were used to identify genome-wide significant (

resultsAfrican-specific (HLA-

conclusionsGenetic risk of type 1 diabetes includes ancestry-specific, disease-associated variants. The GRS developed here provides improved prediction of type 1 diabetes in African-ancestry subjects and a means to identify groups of individuals who would benefit from immune monitoring for early detection of islet autoimmunity.

Indexed as

Genetic TestingAllelesBlack PeopleCase-Control StudiesDiabetes Mellitus, Type 1FemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHLA-D AntigensHLA-DQ alpha-ChainsHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansMalePolymorphism, Single NucleotideHLA-D AntigensHLA-DQA1 antigenHLA-DQ alpha-ChainsHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 Chains

Identifiers

PMID30659077
PMCPMC6385701
OpenAlexW2909528989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.